Stockreport

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

Enveric Biosciences, Inc.  (ENVB) 
PDF Key CMC achievements advance EB-003 on the path to first-in-human trials CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Comp [Read more]